3rd Quarter - Report
ROCK & ASSOCIATES for PRECISION PHARMACY
Firm
Client
Income
$11,250
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to the NASEM report to the FDA on compounded bioidentical hormones, and issues related to GFI #256 on animal drug compounding.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES W ROCK | — |
Budget/Appropriations BUD
Issues related to Appropriations and report language funding the FDA, specifically as it relates to animal drug compounding. No bill numbers yet.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES W ROCK | — |
Pharmacy PHA
Issues related to animal drug compounding. No specific legislation yet.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES W ROCK | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.